BRIEF-Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC Filing

Reuters
01 Apr
BRIEF-Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC Filing

April 1 (Reuters) - Eton Pharmaceuticals Inc ETON.O:

  • ETON PHARMACEUTICALS INC - ESTEVE TO PAY EUR4 MILLION UP FRONT FOR INCRELEX RIGHTS - SEC FILING

  • ETON PHARMACEUTICALS INC - ESTEVE HAS OPTION TO ACQUIRE INTERNATIONAL RIGHTS TO INCRELEX FOR EUR6 MILLION - SEC FILING

Source text: [ID:n0001437749-25-010358]

Further company coverage: ETON.O

(((( Reuters.briefs@thomsonreuters.com ;));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10